Law360, New York (February 17, 2011, 8:53 PM ET) -- Sanofi-Aventis LLC won a preliminary injunction barring Sun Pharmaceuticals Industries Ltd. from selling a generic version of Sanofi's colon cancer drug Eloxatin, after an agreement between the parties to temporarily halt Sun's sales of the drug expired earlier this week.
Judge Joel A Pisano of the U.S. District Court District of New Jersey issued an order Wednesday granting Sanofi's request for the injunction, a day before the agreement with Sun and its subsidiary, Caraco Pharmaceuticals Laboratories Inc., was set to expire.
Sun agreed last week to...
Sanofi Wins Injunction In Sun IP Suit Over Eloxatin
To view the full article, take a free trial now.
